CRVO

1.4609.77%
MV

Marinus Verwijs

Executive Vice President of Technical Operations

Dr. Marinus Verwijs, Ph.D., also known as Marco, is Executive Vice President of Technical Operations of CervoMed Inc. from June 2025. He had been Chief Technical Officer of Adipo Therapeutics, LLC. He was Chief Technical Officer of Aerovate Therapeutics, Inc. since June 2023 and was its Senior Vice President of CMC since March 2022 until 2023. Prior to joining Aerovate, from July 2018 to March 2022, Dr. Verwijs served as a Vice President, Head of Drug Product, Analytical Development and Quality Control at Epizyme, Inc. From December 2014 to June 2018, Dr. Verwijs served as a Director CMC Operations, Head of Process Development and Technical Operations of Flexion Therapeutics, Inc. From January 2009 to August 2014, Dr. Verwijs served as Associate Director Formulation Development for Vertex Pharmaceuticals, Inc. and prior to that, from 2006 to 2009, Dr. Verwijs was employed as Scientist Formulation Development at TransForm Pharmaceuticals, Inc. Dr. Verwijs holds a Ph. D. in Chemical Engineering from University of Florida and has a Master of Science in Chemical Engineering from Delft University of Technology in The Netherlands.

Positions